Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.

Journal of Human Genetics
Seiichi MoriSiew Kee Low

Abstract

There are numerous histological subtypes (histotypes) of gynecological malignancies, with each histotype considered to largely reflect a feature of the "cell of origin," and to be tightly linked with the clinical behavior and biological phenotype of the tumor. The recent advances in massive parallel sequencing technologies have provided a more complete picture of the range of the genomic alterations that can persist within individual tumors, and have highlighted the types and frequencies of driver-gene mutations and molecular subtypes often associated with these histotypes. Several large-scale genomic cohorts, including the Cancer Genome Atlas (TCGA), have been used to characterize the genomic features of a range of gynecological malignancies, including high-grade serous ovarian carcinoma, uterine corpus endometrial carcinoma, uterine cervical carcinoma, and uterine carcinosarcoma. These datasets have also been pivotal in identifying clinically relevant molecular targets and biomarkers, and in the construction of molecular subtyping schemes. In addition, the recent widespread use of clinical sequencing for the more ubiquitous types of gynecological cancer has manifested in a series of large genomic datasets that have allowed th...Continue Reading

References

Apr 10, 1995·American Journal of Medical Genetics·M J SellerG S Tint
Feb 28, 2002·Nature Genetics·Ian P M TomlinsonUNKNOWN Multiple Leiomyoma Consortium
Dec 26, 2003·The American Journal of Pathology·Rainer LehtonenLauri A Aaltonen
Sep 6, 2005·Journal of Medical Genetics·C J van AsperenUNKNOWN Netherlands Collaborative Group on Hereditary Breast Cancer (HEBON)
Dec 3, 2005·The Lancet Oncology·Sheetal AcharyaGini F Fleming
Mar 2, 2006·The Journal of Clinical Endocrinology and Metabolism·Nicolas KalfaCharles Sultan
Oct 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jonathan L Hecht, George L Mutter
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard W TothillDavid D L Bowtell
Feb 6, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dariush EtemadmoghadamUNKNOWN AOCS Study Group
Feb 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kelly D GonzalezJeffrey N Weitzel
Jun 12, 2009·The New England Journal of Medicine·Sohrab P ShahDavid G Huntsman
Sep 12, 2009·Annual Review of Pathology·Jesse J SalkLawrence A Loeb
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 9, 2011·Nature Genetics·Chey LovedayNazneen Rahman
Oct 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tom WalshElizabeth M Swisher
Nov 22, 2011·The Journal of Pathology·Siân JonesIe-Ming Shih
Dec 23, 2011·The New England Journal of Medicine·Alireza Heravi-MoussaviDavid G Huntsman
Jan 19, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Min-Han TanCharis Eng
May 23, 2012·Gynecologic Oncology·Giorgia MangiliMassimo Candiani
Jun 2, 2012·The Journal of Pathology·Melissa K McConechyDavid G Huntsman
Jul 20, 2012·Cancer·Kathryn P PenningtonElizabeth M Swisher
Aug 28, 2012·Journal of the National Cancer Institute·Elisabetta KuhnIe-Ming Shih
Sep 12, 2012·Genes, Chromosomes & Cancer·Eric F P M SchoenmakersAd Geurts van Kessel
Sep 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Prat
Nov 8, 2012·British Journal of Cancer·K KämpjärviP Vahteristo
Dec 14, 2012·Proceedings of the National Academy of Sciences of the United States of America·Brian J BeliveauChao-ting Wu
May 1, 2013·Journal of the National Cancer Institute·Nasim MavaddatUNKNOWN EMBRACE
May 1, 2013·The American Journal of Surgical Pathology·C Blake GilksRobert A Soslow
May 3, 2013·Nature·Cyriac KandothDouglas A Levine
Jun 7, 2013·The New England Journal of Medicine·Miika MehineLauri A Aaltonen
Jun 15, 2013·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Melissa K McConechyDavid G Huntsman
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Oct 23, 2013·The American Journal of Surgical Pathology·Akiko MatsubaraYae Kanai
Jan 7, 2014·Nature·Akinyemi I OjesinaMatthew Meyerson
Mar 25, 2014·Nature Genetics·Petar JelinicDouglas A Levine
Aug 12, 2014·Fertility and Sterility·Miika MehinePia Vahteristo
Sep 19, 2014·The Journal of Pathology·Brooke E HowittBradley J Quade
Oct 2, 2014·Journal of the National Cancer Institute·Gottfried E KonecnyEllen L Goode
Oct 2, 2014·Journal of the National Cancer Institute·Levi WaldronMichael Birrer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.